This elevated copy number burden is found in IDH-mutant astrocytomas with poor clinical outcomes and with additional established poor prognostic molecular features, such as CDKN2A and CDK4, but is also found in cases where no other features suggestive of higher molecular grade are present [71, 96, 98]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).